28 March 2022

New Swiss COVID-19 vaccination as a nasal spray

RocketVax is developing the second-generation COVID-19 vaccine while using the live attenuated SARS-CoV-2 virus vaccine

3 June 2025

Rocketvax Achieves Major Breakthrough in Live-Attenuated SARS-CoV-2 Vaccine Development

12 March 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

16 December 2024

Rocketvax and HALIX Collaborate to Advance the VIRUFLEX(TM) Platform and Next-Generation Nasal COVID-19 Vaccine